Balyasny Asset Management’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.19M | Sell |
2,508
-2,280
| -48% | -$1.15M | ﹤0.01% | 2013 |
|
|
2025
Q4 | $2.24M | Sell |
4,788
-2,382
| -33% | -$1.11M | ﹤0.01% | 1801 |
|
|
2025
Q3 | $3.06M | Sell |
7,170
-116,049
| -94% | -$45M | ﹤0.01% | 1607 |
|
|
2025
Q2 | $47.2M | Buy |
123,219
+121,195
| +5,988% | +$43.7M | 0.07% | 351 |
|
|
2025
Q1 | $699K | Sell |
2,024
-7,382
| -78% | -$2.37M | ﹤0.01% | 2147 |
|
|
2024
Q4 | $2.82M | Sell |
9,406
-1,879
| -17% | -$657K | ﹤0.01% | 1539 |
|
|
2024
Q3 | $4.59M | Buy |
11,285
+9,325
| +476% | +$3.41M | 0.01% | 1287 |
|
|
2024
Q2 | $630K | Sell |
1,960
-7,801
| -80% | -$2.53M | ﹤0.01% | 1968 |
|
|
2024
Q1 | $3.26M | Sell |
9,761
-226,355
| -96% | -$69.2M | 0.01% | 1381 |
|
|
2023
Q4 | $63.9M | Buy |
236,116
+232,829
| +7,083% | +$57.5M | 0.12% | 214 |
|
|
2023
Q3 | $809K | Buy |
3,287
+124
| +4% | +$33.9K | ﹤0.01% | 1615 |
|
|
2023
Q2 | $960K | Sell |
3,163
-8,351
| -73% | -$2.32M | ﹤0.01% | 1638 |
|
|
2023
Q1 | $3.04M | Buy |
11,514
+9,350
| +432% | +$2.38M | 0.01% | 1283 |
|
|
2022
Q4 | $519K | Sell |
2,164
-1,851
| -46% | -$415K | ﹤0.01% | 1849 |
|
|
2022
Q3 | $738K | Sell |
4,015
-812
| -17% | -$162K | ﹤0.01% | 1921 |
|
|
2022
Q2 | $811K | Buy |
+4,827
| New | +$1.04M | ﹤0.01% | 1832 |
|
|
2022
Q1 | – | Sell |
-69,764
| Closed | -$17.9M | – | 2624 |
|
|
2021
Q4 | $17.9M | Sell |
69,764
-78,595
| -53% | -$19.2M | 0.06% | 456 |
|
|
2021
Q3 | $36M | Buy |
+148,359
| New | +$36.3M | 0.15% | 180 |
|
|
2020
Q4 | – | Sell |
-102,436
| Closed | -$12.8M | – | 1486 |
|
|
2020
Q3 | $12.8M | Buy |
+102,436
| New | +$12.7M | 0.09% | 320 |
|
|
2020
Q1 | – | Sell |
-117,658
| Closed | -$15.2M | – | 1285 |
|
|
2019
Q4 | $17.4M | Sell |
117,658
-4,343
| -4% | -$583K | 0.1% | 293 |
|
|
2019
Q3 | $14.7M | Buy |
122,001
+114,278
| +1,480% | +$14.8M | 0.1% | 301 |
|
|
2019
Q2 | $1.04M | Sell |
7,723
-37,563
| -83% | -$4.75M | 0.01% | 1066 |
|
|
2019
Q1 | $5.9M | Buy |
45,286
+33,344
| +279% | +$4.48M | 0.04% | 534 |
|
|
2018
Q4 | $1.49M | Sell |
11,942
-75,543
| -86% | -$10.1M | 0.01% | 793 |
|
|
2018
Q3 | $12.2M | Sell |
87,485
-25,006
| -22% | -$3.11M | 0.06% | 428 |
|
|
2018
Q2 | $11.5M | Buy |
112,491
+101,922
| +964% | +$10.3M | 0.05% | 450 |
|
|
2018
Q1 | $1.02M | Sell |
10,569
-237,755
| -96% | -$23.1M | ﹤0.01% | 1196 |
|
|
2017
Q4 | $21.8M | Buy |
248,324
+230,642
| +1,304% | +$18.5M | 0.07% | 371 |
|
|
2017
Q3 | $1.41M | Buy |
+17,682
| New | +$1.42M | 0.01% | 1069 |
|
|
2017
Q2 | – | Sell |
-7,500
| Closed | -$667K | – | 1573 |
|
|
2017
Q1 | $667K | Sell |
7,500
-214,419
| -97% | -$17.9M | ﹤0.01% | 1230 |
|
|
2016
Q4 | $16.4M | Buy |
221,919
+8,665
| +4% | +$649K | 0.09% | 329 |
|
|
2016
Q3 | $16.1M | Sell |
213,254
-84,488
| -28% | -$6.47M | 0.09% | 295 |
|
|
2016
Q2 | $22.9M | Sell |
297,742
-318,562
| -52% | -$25.1M | 0.15% | 179 |
|
|
2016
Q1 | $48.1M | Buy |
+616,304
| New | +$43M | 0.29% | 90 |
|
|
2015
Q3 | – | Sell |
-3,010
| Closed | -$273K | – | 1236 |
|
|
2015
Q2 | $273K | Sell |
3,010
-1,550
| -34% | -$124K | ﹤0.01% | 971 |
|
|
2015
Q1 | $343K | Buy |
+4,560
| New | +$327K | ﹤0.01% | 759 |
|
|
2014
Q3 | – | Sell |
-247,723
| Closed | -$14M | – | 769 |
|
|
2014
Q2 | $14M | Sell |
247,723
-26,660
| -10% | -$1.41M | 0.16% | 161 |
|
|
2014
Q1 | $14.4M | Sell |
274,383
-205,618
| -43% | -$10.2M | 0.16% | 160 |
|
|
2013
Q4 | $22.9M | Sell |
480,001
-270,975
| -36% | -$12.5M | 0.3% | 86 |
|
|
2013
Q3 | $32.1M | Buy |
750,976
+475,978
| +173% | +$18.6M | 0.43% | 39 |
|
|
2013
Q2 | $9.92M | Buy |
+274,998
| New | +$10.6M | 0.17% | 149 |
|
Other funds holding HCA
VCM
VPM
Balyasny Asset Management's HCA Position: Q1 2026 in Review
Balyasny Asset Management reduced its HCA Healthcare (HCA) stake by 48% in Q1 2026, selling an estimated $1.15M and leaving 2,508 shares worth $1.19M. The position accounts for ﹤0.01% of the portfolio, ranked #2013.
Balyasny Asset Management first reported a position in HCA in Q2 2013 and has held it in 41 quarters since. The position peaked at $63.9M in Q4 2023. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- Balyasny Asset Management held 2,508 shares of HCA Healthcare worth $1.19M as of Q1 2026.
- Balyasny Asset Management sold 2,280 HCA Healthcare shares in Q1 2026, an estimated $1.15M.
- HCA Healthcare made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #2013 holding.
- Balyasny Asset Management first reported a position in HCA Healthcare in Q2 2013 and has held it in 41 quarters since.
- Balyasny Asset Management's HCA Healthcare position peaked at $63.9M in Q4 2023.
- 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.